KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Debt to Equity (2016 - 2025)

Resmed's Debt to Equity history spans 16 years, with the latest figure at $0.04 for Q4 2025.

  • For Q4 2025, Debt to Equity rose 2080.46% year-over-year to $0.04; the TTM value through Dec 2025 reached $0.04, up 2080.46%, while the annual FY2025 figure was $0.0, 18.5% down from the prior year.
  • Debt to Equity reached $0.04 in Q4 2025 per RMD's latest filing, down from $0.04 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.04 in Q3 2025 to a low of $0.0 in Q2 2025.
  • Average Debt to Equity over 5 years is $0.01, with a median of $0.0 recorded in 2022.
  • Peak YoY movement for Debt to Equity: crashed 31.02% in 2023, then skyrocketed 2128.9% in 2025.
  • A 5-year view of Debt to Equity shows it stood at $0.0 in 2021, then plummeted by 30.57% to $0.0 in 2022, then fell by 16.61% to $0.0 in 2023, then decreased by 14.61% to $0.0 in 2024, then surged by 2080.46% to $0.04 in 2025.
  • Per Business Quant, the three most recent readings for RMD's Debt to Equity are $0.04 (Q4 2025), $0.04 (Q3 2025), and $0.0 (Q2 2025).